Inhaled corticosteroid for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials

CONCLUSIONS: Additional ICS use, particularly inhaled budesonide may help symptom relief in patients with COVID-19. However, ICS use did not help reduce the risk of urgent care, ED visit, hospitalization, or death.PMID:37562996 | DOI:10.1016/j.jmii.2023.07.008

Source: Journal of Microbiology, Immunology, and Infection - August 10, 2023 Category: Microbiology Authors: Chin-Wei Hsu Mei-Chuan Lee Yi-Ming Hua Chih-Cheng Lai Hung-Jen Tang Chien-Ming Chao Source Type: research